It should be noted that senescent T cells in AML have been found to possess increased IFNγ and TNFα potential, though lower IL-2 [18], which differs to what we and many others have demonstrated regarding MSC immunosuppression. The gene discussed is TNF; the disease is acute myeloid leukemia.